LIASON 1-84 PTH Assay, LIASON 1-84 PTH Control Set, LIASON 1-84 PTH Calibration Verifiers
Radioimmunoassay, Parathyroid Hormone. 510(k) K150879, from DiaSorin, Inc. (Stillwater, MN). Product code CEW, class 2.
As of Nov 20, 2026, K150879 is an FDA 510(k) held by DiaSorin, Inc., substantially equivalent on Jun 22, 2015 after 82 days, with 1 recall tied to it in FDA's recall database.
- Review time: 82 days
- Recalls: 1
- Cited as a predicate by: 1 device
The DiaSorin LIAISON® 1-84 PTH assay is an in vitro chemiluminescent immunoassay (CLIA) intended for the quantitative determination of parathyroid hormone (1-84) in human serum and EDTA plasma. Measurements of parathyroid hormone levels are used in the differential diagnosis of hypercalcemia and hypocalcemia resulting from disorders of calcium metabolism.
- Whole Pth (1-84) Specific Immunoradiometric Irma Diagnostic Assay Kit, Model 3KG056K001411 · Scantibodies Laboratory, Inc. · Aug 21, 2000
- Liaison N-Tact PthK033426 · DiaSorin, Inc. · Feb 12, 2004
- Liaison N-Tact Pth Calibration Verifiers Model 310913K093498 · DiaSorin, Inc. · Dec 14, 2009
- Lumipulse G whole PTHK190702 · Fujirebio Diagnostics,Inc. · Aug 30, 2019
| Started | Recall | Status |
|---|---|---|
| Nov 23, 2020 | Z-1342-2021Potential for system to produce falsely elevated parathyroid hormone (PTH) results from patient samples. | Terminated |
- Elecsys PTH , Elecsys PTH STATK231927 · Roche Diagnostics · Mar 22, 2024
- Access Intact PTHK232791 · Beckman Coulter, Inc. · Mar 1, 2024
- VITROS Immunodiagnostic Products Intact PTH II Reagent PackK221197 · Ortho Clinical Diagnostics · Sep 5, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 1, 2015
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1545
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files